Jacob Ma-Weaver
CIK 1922140 · last filed 2024-08-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
12
Lifetime Open-Market Net
$4.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ABIO) Delisted | Director | 6,580,904 | $28.80 | $189.53M | $2.20M | 11 | 2024-08-30 |
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 406,400 | $3.20 | $1.30M | $1.88M | 1 | 2023-09-22 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-12 | Oruka Therapeutics, Inc. (ABIO) Delisted | Buy (P) | +209,426 | $485.5K | EDGAR |
| 2022-04-07 | Oruka Therapeutics, Inc. (ABIO) Delisted | Buy (P) | +207,968 | $479.6K | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.